Back to News
Market Impact: 0.5

HRTG vs. UVE: Which Regional P&C Insurer is a Safer Bet Now?

HRTGUVE
Company FundamentalsCorporate EarningsAnalyst EstimatesNatural Disasters & WeatherTechnology & InnovationBanking & LiquidityCapital Returns (Dividends / Buybacks)Analyst Insights
HRTG vs. UVE: Which Regional P&C Insurer is a Safer Bet Now?

Regional P&C insurers Heritage Insurance (HRTG) and Universal Insurance (UVE), both heavily exposed to the Florida homeowners market, are expected to grow despite catastrophe risks due to improved pricing and state-level support. Heritage Insurance, with a Zacks Rank #1 (Strong Buy), is considered a safer bet than Universal Insurance, which carries a Zacks Rank #2 (Buy); HRTG's 2025 revenue and EPS are projected to increase 4.6% and 61.7% respectively, while UVE's revenue is expected to decrease 2.1% but EPS to increase 48%. HRTG's return on equity is 33.5% compared to UVE's 16.8%.

Analysis

The Florida-focused property and casualty insurance sector is demonstrating resilience, supported by state initiatives like reduced reinsurance costs and legal system reforms, alongside insurers' own strategies involving digitalization and improved pricing. Within this environment, Heritage Insurance Holdings (HRTG) presents a compelling case, having significantly improved its net margin to 9.3% in the first quarter from a negative 16.1% two years prior, and boasting a return on equity of 33.5%, well above the industry average of 7.8%. HRTG's strategic focus on profitability includes halting new personal lines policy issuance in Florida and the Northeast as of December 2022, expanding its excess and surplus (E&S) lines, and securing its 2025–2026 reinsurance program, which is anticipated to lower its ceded premium ratio. The company projects a 4.6% revenue increase and a substantial 61.7% EPS growth for 2025, supported by a $10 million share buyback program and a Zacks Rank #1 (Strong Buy). Conversely, Universal Insurance Holdings (UVE), while also investing in technology and diversifying its portfolio, faces a projected 2.1% revenue decline in 2025, though its EPS is expected to grow by 48% and its return on equity stands at 16.8%. Both HRTG and UVE shares have outperformed the industry year-to-date, gaining 91% and 25% respectively, and currently trade above their five-year median price-to-book multiples—HRTG at 2.16 (median 0.68) and UVE at 1.76 (median 1.22)—indicating heightened investor optimism.